Biora Therapeutics (BIOR) News Today $1.58 -0.04 (-2.47%) (As of 12:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Biora Therapeutics (NASDAQ:BIOR) Price Target Raised to $23.00November 21 at 2:13 AM | americanbankingnews.comBiora Therapeutics Faces Nasdaq Delisting ChallengesNovember 15, 2024 | markets.businessinsider.comBiora Therapeutics Reports Q3 2024 Results and UpdatesNovember 15, 2024 | markets.businessinsider.comBiora Therapeutics, Inc.: Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial ResultsNovember 14, 2024 | finanznachrichten.deBiora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial ResultsNovember 14, 2024 | markets.businessinsider.comBiora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial ResultsNovember 14, 2024 | globenewswire.comBiora Therapeutics (BIOR) Scheduled to Post Quarterly Earnings on ThursdayNovember 12, 2024 | americanbankingnews.comBiora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate UpdateNovember 7, 2024 | globenewswire.comBiora Therapeutics announces $3 million stock and warrant saleOctober 31, 2024 | investing.comBiora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesOctober 29, 2024 | globenewswire.comBiora shares progress on its development of BioJet Oral Delivery PlatformOctober 28, 2024 | markets.businessinsider.comBiora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD MeetingOctober 28, 2024 | globenewswire.comBiora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery MeetingOctober 14, 2024 | markets.businessinsider.comBiora Therapeutics (NASDAQ:BIOR) Stock, Short Interest ReportOctober 10, 2024 | benzinga.comBiora Therapeutics (NASDAQ:BIOR) Stock Quotes, Forecast and News SummaryOctober 10, 2024 | benzinga.comBiora Therapeutics to Present at the 19th Annual Peptide Therapeutics SymposiumOctober 7, 2024 | markets.businessinsider.comBiora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024September 30, 2024 | finance.yahoo.comBIOR Stock Earnings: Biora Therapeutics Beats EPS for Q1 2024September 23, 2024 | msn.comBiora Therapeutics Achieves ISO 13485 CertificationSeptember 9, 2024 | markets.businessinsider.comBiora Therapeutics Announces Positive Nasdaq Listing DecisionAugust 28, 2024 | markets.businessinsider.comBiora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment ConferenceAugust 26, 2024 | globenewswire.comBGLC Stock Earnings: BioNexus Gene Lab Reported Results for Q2 2024August 20, 2024 | markets.businessinsider.comBiora Therapeutics, Inc.: Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial ResultsAugust 18, 2024 | finanznachrichten.deBIOR: Second Quarter ResultsAugust 17, 2024 | finance.yahoo.comBiora Therapeutics Second Quarter 2024 Earnings: EPS: US$0.18 (vs US$1.47 loss in 2Q 2023)August 15, 2024 | uk.finance.yahoo.comQ2 2024 Biora Therapeutics Inc Earnings CallAugust 13, 2024 | finance.yahoo.comCrypto Project Essential Raises $11M for 'Intent-Based' BlockchainAugust 13, 2024 | msn.comBiora Therapeutics: Outperforming with Strong Q2 Financials and Clinical AdvancementsAugust 13, 2024 | markets.businessinsider.comBiora Therapeutics, Inc. (NASDAQ:BIOR) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | msn.comBIOR Stock Earnings: Biora Therapeutics Beats EPS for Q2 2024August 12, 2024 | investorplace.comBiora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial ResultsAugust 12, 2024 | globenewswire.comBiora Therapeutics Announces Funding Agreement with Existing InvestorsAugust 12, 2024 | globenewswire.comBiora Therapeutics to Report Second Quarter 2024 Financial Results and Provide Corporate UpdateAugust 8, 2024 | globenewswire.comBiora Therapeutics to Participate in Canaccord Genuity 44th Annual Growth ConferenceAugust 6, 2024 | finance.yahoo.comBiora Therapeutics, Inc. (BIOR)July 26, 2024 | finance.yahoo.comBiora Therapeutics Buy Rating Confirmed by Positive Phase 1 Trial Outcomes and NaviCap Technology PotentialJuly 22, 2024 | markets.businessinsider.comBiora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL EventJuly 19, 2024 | markets.businessinsider.comBiora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024June 11, 2024 | globenewswire.comBiora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024May 20, 2024 | globenewswire.comBiora Therapeutics, Inc.: Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsMay 16, 2024 | finanznachrichten.deBIOR: BT-600 Data in JuneMay 16, 2024 | finance.yahoo.comBiora Therapeutics, Inc. (NASDAQ:BIOR) Q1 2024 Earnings Call TranscriptMay 16, 2024 | msn.comBiora Therapeutics Inc (BIOR) Q1 2024 Earnings Call Transcript Highlights: Navigating Through ...May 16, 2024 | finance.yahoo.comBiora Therapeutics GAAP EPS of -$0.14 beats by $0.31, revenue of $0.54MMay 15, 2024 | msn.comBiora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsMay 15, 2024 | finance.yahoo.comBiora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsMay 15, 2024 | globenewswire.comBiora Therapeutics to Report First Quarter 2024 Financial Results and Provide Corporate UpdateMay 7, 2024 | finance.yahoo.comBiora Therapeutics to Present Clinical Data on Device Function of the NaviCap™ Oral Delivery Platform at Digestive Disease Week 2024May 6, 2024 | globenewswire.comBiora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600April 30, 2024 | globenewswire.comBiora Therapeutics (BIOR) Price Target Decreased by 62.95% to 10.51April 18, 2024 | msn.com Get Biora Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOR and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. BIOR Media Mentions By Week BIOR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIOR News Sentiment▼-0.290.47▲Average Medical News Sentiment BIOR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIOR Articles This Week▼52▲BIOR Articles Average Week Get Biora Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Centogene News Today Renalytix News Today RenovoRx News Today Daré Bioscience News Today Tonix Pharmaceuticals News Today DURECT News Today Longeveron News Today BioLineRx News Today MiNK Therapeutics News Today Natural Alternatives International News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIOR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biora Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
